Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045, India
[250 Pages Report] The global implantable collamer lens market is expected to reach a valuation of US$ 244.8 Mn in 2022. Demand is projected to increase at a CAGR of 13.1% over the forecast period, with the market size reaching US$ 838.2 Mn by 2032.
According to the recent study by Future Market Insights (FMI), the myopia disease indication is leading the market with a share of around 78.2% in the year 2021.
Attributes | Key Insights |
---|---|
Implantable Collamer Lens Market Base Year Value (2021) | US$ 212.9 Million |
Estimated Market Size (2022) | US$ 244.8 Million |
Projected Market Valuation (2032) | US$ 838.2 Million |
Value-based CAGR (2022 to 2032) | 13.1% |
Key Market Players | STAAR SURGICAL |
Implantable collamer lens are an example of a posterior chamber phakic intraocular lens (pIOL). When corneal refractive surgery is not an option with substantial levels of refractive error, pIOL are employed. Faster healing and reversibility are benefits of implantable collamer lens over corneal refractive surgery, because they are less apparent from the outside and pose a lower risk of endothelial cell loss (ECL) due to being positioned farther from the cornea than anterior chamber (AC).
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales in the implantable collamer lens represented 16.0% of the overall US$ 4.9 Bn worth global intraocular lenses market in 2021.
There are few surgical alternatives available for correcting refractive defect in patients with extreme myopic astigmatism. Patients with low to moderate myopic astigmatism are preferred candidates for corneal refractive procedures including photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK), as these techniques are constrained by corneal thickness and keratometry for safe ablation.
In individuals with severe myopic astigmatism, over-ablation can lead to higher order aberrations and other postoperative problems such corneal ectasia. By dividing the significant refractive correction between a corneal laser ablation and an implantable collamer lens, Bioptics attempts to overcome this constraint.
The U.S. FDA Post Approval Study (PAS) of the Implantable Collamer Lens for Myopia (MICL) has produced long-term data which has added to the current understanding of safety in regard to the occurrence of endothelial cell loss, cataract, and elevated intraocular pressure.
The most popular treatment for correcting refractive defects uses an excimer laser to reshape the cornea, and is known as laser-assisted in situ keratomileusis (LASIK). However, there are restrictions when used to fix high refractive cylinder. The results of LASIK for myopic astigmatism may be affected by the presence of ocular residual astigmatism, discrepancy between refractive and topographic astigmatism axis, and the influence of internal optical astigmatism.
Currently, using small incision lenticule extraction (SMILE) to treat low to moderate myopia is widely accepted. However, SMILE has its own intrinsic limitations, including thick ablation depths, limited ablation zones, and greater aberrations. SMILE could also raise the risk of haze, corneal ectasia, myopic regression, and dry eye.
The postoperative spherical equivalent error (SER) is observed to be predictable and consistent, making implantable collamer lens (ICL) implantation a promising technique for high myopia correction.
By including patients with thin corneas and even keratoconus, ICL implantation broadened the target population. Studies that compared ICL implantation with SMILE for the treatment of high myopia reached conflicting conclusions. However, widely accepted results of ICL implantation have reportedly outperformed SMILE in terms of higher-order aberrations (HOAs), refractive correctness, and uncorrected distance visual acuity.
Backed by these factors, the adoption of implantable collamer lens is expected to gain traction at a considerable pace.
ICL is regarded as a cosmetic procedure, similar to LASIK, and is most likely not covered under insurance coverage. Due to the personalised nature of implants, an ICL is often more expensive per eye than LASIK.
Despite the fact that ICLs are designed to last indefinitely, it is still advised to schedule routine follow-up appointments to make sure the implants are in place and to check for premature cataracts, which could necessitate cataract surgery and raise intraocular pressure. These factors might limit the adoption of ICLs.
“Rising Demand for Implantable Contact Lens in China Will Boost Sales”
China dominated the East Asia implantable collamer lens market, accounting for around 46.6% of the total market share in 2021. As per FMI, the trend is expected to continue over the forecast period.
With the approval of STAR SURGICAL’s Visian Implantable Collamer Lens with CentraFLOW technology in China in 2014, the country is witnessing advancements in the field of optical products, which is expected to augment the growth in the market.
“High Influx of Medical Tourists in the U.K. Will Fuel Sales of Implantable Collamer Lens”
Europe accounted for nearly 26.1% of the global implantable collamer lens market in 2021, with the U.K. emerging as a lucrative pocket. The first implants of the 2011 CE Mark-approved Visian® Implantable Collamer® Lens (ICL(TM)) by STAR SURGICAL were performed in the Europe.
Before the product's complete market debut in the nations that receive CE Mark approvals, these were the initial steps in the company's pre-launch plan for the product at eight sites and 100 eyes.
“Increasing Adoption of Collamer Lens Surgery in Japan Will Spur Growth”
The Japan implantable collamer lens market held around 17.8% of the global market share in 2021. In Japan, ICL clinical studies began in 2003 and were eventually approved by the Ministry of Health, Labor, and Welfare in 2010.
Prior to the development of Hole ICLs, postoperative complications from glaucoma and cataract surgery were an issue for early ICLs. However, these complications are no longer a problem because of Hole ICLs.
Only ten highly qualified instructors are now authorised to observe and licence the surgery of doctors who desire to operate an ICL in Japan. As a result, demand for implantable collamer lens in Japan is forecast to increase at a considerable pace.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Demand for Implantable Collamer Lens for Myopia Will Remain High”
Based on indication, the myopia segment accounted for 78.2% of the total market share in 2021. Sales in this segment are expected to grow at a 12.6% CAGR over the forecast period. High prevalence of myopic disorders have given way to addressing several indications related to refractive diseases which are highly prevalent globally. The myopic segment of indication is a prime driver for the f implantable collamer lenses market.
“Adoption of Implantable Collamer Lens in Hospital Settings is More Preferred”
In terms of end user, the hospitals segment held 52.4% of the total market share in 2021. Large number of procedures performed with reference to implantable ocular surgeries are undertaken within hospital settings. Prime driver for the same includes the availability of surgical equipment, implants, and the progression of the surgical procedure in the presence of skilled professions.
STAR SURGICAL dominates the market for implantable collamer lenses. Only one posterior chamber phakic IOL (PIOL) has been given FDA marketing and sales approval in the U.S., and that is the implantable collamer lens manufactured by STAAR SURGICAL.
Attribute | Details |
---|---|
Estimated Market Size (2022) | US$ 244.8 Million |
Projected Market Valuation (2032) | US$ 838.2 Million |
Value-based CAGR (2022 to 2032) | 13.1% |
Forecast Period | 2017 to 2021 |
Historical Data Available for | 2022 to 2032 |
Market Analysis | US$ Mn for Value |
Key Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, MEA |
Key Market Segments Covered | Indication, End User, and Region |
Key Company Profiled | STAAR SURGICAL |
Pricing | Available upon Request |
1. Executive Summary 1.1. Global Market Outlook 1.2. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions & Exclusions 3. Key Market Trends 3.1. Demand Side Trends 3.2. Supply Side Trends 4. Key Success Factors 4.1. Disease Epidemiology, by Region 4.2. Product and Technology Assessment 4.3. Regulatory Landscape 4.4. Reimbursement Scenario 4.5. Rise in Demand for Implantable Collamer Lenses 4.6. PESTEL Analysis 4.7. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Top Companies Historical Growth 5.2.2. Rising Geriatric Population 5.2.3. Adoption of LASIK Procedures 5.2.4. Growing Volumes of Refractive Surgery 5.2.5. Cost of Lens Implantation 5.2.6. High Prevalence of Diabetic Population Group 5.2.7. Global Epidemiology of Cataract 5.2.8. Rising Government Support to Control and Treat Blindness 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis Analysis 6.1. Current COVID-19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 Economic analysis 6.4. COVID-19 and Impact Analysis 6.4.1. By Indication 6.4.2. By End User 6.5. 2021 Market Scenario 7. Global Implantable Collamer Lens Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032 7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by Indication 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Indication Type, 2017–2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2022–2032 8.3.1. Myopia 8.3.2. Hyperopia 8.3.3. Astigmatism 8.4. Market Attractiveness Analysis By Indication 9. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by End User 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032 9.3.1. Hospitals 9.3.2. Ophthalmic Clinics 9.3.3. Ambulatory Surgical Centers 9.3.4. Eye Research Institutes 9.4. Market Attractiveness Analysis By End User 10. Global Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032, by Region 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032 10.3.1. US 10.3.2. Europe 10.3.3. China 10.3.4. Japan 10.3.5. ROW 10.4. Market Attractiveness Analysis By Region 11. U.S. Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 11.3.1. By Indication 11.3.2. By End User 11.4. Market Attractiveness Analysis 11.5. Key Market Participants - Intensity Mapping 11.6. Drivers and Restraints - Impact Analysis 12. China Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 12.3.1. By Indication 12.3.2. By End User 12.4. Market Attractiveness Analysis 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 13. Europe Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 13.3.1. By Indication 13.3.2. By End User 13.4. Market Attractiveness Analysis 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 14. Japan Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 14.3.1. By Indication 14.3.2. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Rest of the World Implantable Collamer Lens Market Analysis 2017–2021 and Forecast 2022–2032 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2021 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032 15.3.1. By Indication 15.3.2. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 16.4.1. By Regional footprint of Players 16.4.2. Indication footprint of Players 16.4.3. Chanel footprint of Players 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. STAAR SURGICAL 17.3.1.1. Overview 17.3.1.2. Indication Portfolio 17.3.1.3. Key Financials 17.3.1.4. SWOT Analysis 17.3.1.5. Sales Footprint 17.3.1.6. Analyst Commentary 17.3.1.7. Strategy Overview 17.3.1.7.1. Marketing Strategy 17.3.1.7.2. Indication Strategy 17.3.1.7.3. Channel Strategy 18. Assumptions and Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 01: Global Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication Table 02: Global Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022-2032, By End User Table 03: Global Implantable Collamer Lens Market Value (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Region Table 04: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 05: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication Table 06: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 07: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 08: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication Table 09: China Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 10: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 11: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication Table 12: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 13: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 14: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication Table 15: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User Table 16: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country Table 17: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032, By Indication Table 18: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Figure 01: Global Implantable Collamer Lens Market, By Indication, 2022E Figure 02: Global Implantable Collamer Lens Market, By End User, 2022E Figure 03: Global Implantable Collamer Lens Market, By Region, 2022E Figure 04: Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021 Figure 05: Global Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), Analysis, 2022-2032 Figure 06: Global Implantable Collamer Lens Market Absolute $ Opportunity Analysis, 2022-2032 Figure 07: Global Implantable Collamer Lens Market Analysis by Indication–2022 & 2032 Figure 08: Global Implantable Collamer Lens Market Y-o-Y Growth Projections by Indication, 2022-2032 Figure 09: Global Implantable Collamer Lens Market Attractiveness Analysis, By Indication Figure 10: Global Implantable Collamer Lens Market Analysis by End User–2022 & 2032 Figure 11: Global Implantable Collamer Lens Market Y-o-Y Growth (%) By End User, 2022-2032 Figure 12: Global Implantable Collamer Lens Market Attractiveness Analysis, By End User Figure 13: Global Implantable Collamer Lens Market Share Analysis (%) by Region, 2022 & 2032 Figure 14: Global Implantable Collamer Lens Market Y-o-Y Growth (%) by Region, 2022–2032 Figure 15: Global Implantable Collamer Lens Market Attractiveness Analysis, By Region Figure 16: U.S. Implantable Collamer Lens Market Value Share, By Country (2022F) Figure 17: U.S. Implantable Collamer Lens Market Value Share, By Indication (2022E) Figure 18: U.S. Implantable Collamer Lens Market Value Share, By End User (2022E) Figure 19: U.S. Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021 Figure 20: U.S. Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 21: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By Indication Figure 22: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By End User Figure 23: U.S. Implantable Collamer Lens Market Attractiveness Analysis, By Country Figure 24: China Implantable Collamer Lens Market Value Share, By Country (2022F) Figure 25: China Implantable Collamer Lens Market Value Share, By Indication (2022E) Figure 26: China Implantable Collamer Lens Market Value Share, By End User (2022E) Figure 27: China Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021 Figure 28: China Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 29: China Implantable Collamer Lens Market Attractiveness Analysis, By Indication Figure 30: China Implantable Collamer Lens Market Attractiveness Analysis, By End User Figure 31: China Implantable Collamer Lens Market Attractiveness Analysis, By Country Figure 32: Europe Implantable Collamer Lens Market Value Share, By Country (2022F) Figure 33: Europe Implantable Collamer Lens Market Value Share, By Indication (2022E) Figure 34: Europe Implantable Collamer Lens Market Value Share, By End User (2022E) Figure 35: Europe Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021 Figure 36: Europe Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 37: Europe Implantable Collamer Lens Market Attractiveness Analysis, By Indication Figure 38: Europe Implantable Collamer Lens Market Attractiveness Analysis, By End User Figure 39: Europe Implantable Collamer Lens Market Attractiveness Analysis, By Country Figure 40: Japan Implantable Collamer Lens Market Value Share, By Country (2022F) Figure 41: Japan Implantable Collamer Lens Market Value Share, By Indication (2022E) Figure 42: Japan Implantable Collamer Lens Market Value Share, By End User (2022E) Figure 43: Japan Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021 Figure 44: Japan Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 45: Japan Implantable Collamer Lens Market Attractiveness Analysis, By Indication Figure 46: Japan Implantable Collamer Lens Market Attractiveness Analysis, By End User Figure 47: Japan Implantable Collamer Lens Market Attractiveness Analysis, By Country Figure 48: Rest of the World Implantable Collamer Lens Market Value Share, By Country (2022E) Figure 49: Rest of the World Implantable Collamer Lens Market Value Share, By Indications (2022E) Figure 50: Rest of the World Implantable Collamer Lens Market Value Share, By End User (2022E) Figure 51: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) Analysis, 2017-2021 Figure 52: Rest of the World Implantable Collamer Lens Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2032 Figure 53: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By Indication Figure 54: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By End User Figure 55: Rest of the World Implantable Collamer Lens Market Attractiveness Analysis, By Country
Recommendations
Explore Healthcare Insights
View Reports